Ascendis Pharma Grants 27,030 Employee Warrants and Updates Articles of Association

On June 9, 2026, Ascendis Pharma A/S announced that its Board of Directors granted an aggregate of 27,030 warrants to certain employees under the company's Articles of Association. Each warrant grants the holder the right to subscribe for one ordinary share of the company at an exercise price of $213.23, which reflects the closing price of the company's shares on the date of the grant. The warrants are subject to a four-year vesting schedule: 25% of the warrants will vest on the one-year anniversary of the grant date, with the remaining 75% vesting in equal monthly installments over the following 36 months, provided the employee remains in service. Following this grant, Ascendis Pharma reported that 1,553,563 warrants remain available for future issuance under its current authorizations. In conjunction with this grant, the company updated its Articles of Association to reflect the changes in issued warrants and the corresponding potential increase in share capital.